At a glance
- Originator Hokuriku Seiyaku
- Class Antiasthmatics; Small molecules
- Mechanism of Action Leukotriene D4 receptor antagonists; Thromboxane A2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 18 Dec 2003 No development reported - Preclinical for Asthma in Japan (unspecified route)
- 13 Mar 2001 BASF's pharmaceutical business has been acquired by Abbott Laboratories
- 14 Sep 1999 Preclinical development for Asthma in Japan (Unknown route)